Ars Pharmaceuticals Inc (SPRY)

Investing Cash Flow

$41.57M

Quarterly · Period ending: · USD

SPRY logo

SPRY Investing Cash Flow

Latest reported$41.57M
SPRY Quarterly Cash from Investing (-$33.00K → $41.57M)
High-resolution chart · PNG

SPRY investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
41,572,000
27,791,000
24,114,000
-44,981,000
48,571,000
29,064,000
-101,760,000
16,818,000
-12,646,000
-8,513,000
26,039,000
-46,643,000
44,970,000
-111,546,000
-126,000
-30,000
-22,000
-21,000
-25,685,000
-40,058,000
-700,000
-35,000
-5,000
-33,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.